• Info
  • Insider Ownership

Insider Trading & Ownership of Jonathan David Schwartz

Location
New York, NY
Summary
The estimated net worth of Jonathan David Schwartz is at least $2,692,124 dollars as of 20 Nov 2025. Jonathan David Schwartz is the Chief Science & Gene Therapy Officer of ROCKET PHARMACEUTICALS, INC. and owns shares of ROCKET PHARMACEUTICALS, INC. (RCKT) stock worth about $2.69M.
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
All Insider Reports
All Insider Reports

Notify me when Jonathan David Schwartz files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jonathan David Schwartz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RCKT, RCKTW ROCKET PHARMACEUTICALS, INC. Chief Science & Gene Therapy Officer $2,692,124 -$133,447 -4.7% 18 Nov 2025
TRHC Tabula Rasa HealthCare, Inc. Director 03 Nov 2023

Insider Transactions Reported by Jonathan David Schwartz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.